Generated by AI
Microbot Medical Inc. is a medical device company focused on robotic technologies for minimally invasive procedures. Its current product portfolio centers on the LIBERTY Endovascular Robotic System, a disposable robotic platform designed to support catheter-based interventions in cardiovascular, peripheral, endovascular, and neurovascular care. The company also works on robotic endoluminal surgery devices aimed at improving precision and control in complex vascular pathways. Microbot Medical Inc. operates in the healthcare technology and medical devices market, where its systems are intended to help clinicians perform procedures with greater remote control and workflow efficiency. Headquartered in Hingham, Massachusetts, the company concentrates on developing specialized tools for interventional medicine and robotic-assisted procedure delivery.
Website175 Derby Street
Hingham, MA, 02043
United States
The latest articles about MBOT.
The fair value estimate for Microbot Medical has been reduced from US$6.33 to about US$5.38, a move that reflects a roughly 15% cut to the price target. Recent analyst commentary ties this shift to a more cautious view on how quickly hospitals may adopt the Liberty system and convert early interest into recurring orders. As you read on, you will see how these updated assumptions shape the evolving Microbot Medical story and what to watch next. Stay updated as the Fair Value for Microbot...
Summary of Nov 16's posts. Generated by AI.
Summary of Oct 28's posts. Generated by AI.
Summary of Jan 13's posts. Generated by AI.
Summary of Jun 28's posts. Generated by AI.
Investors talking about MBOT also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.